Interim Pillar 3 Disclosures
2024
Q2 2024 Pillar 3 report
Introduction | 1 |
Annex I: Key metrics and overview of risk weighted exposure amounts | |
Table 1: UK KM1 - Key metrics | 2 |
Table 2: UK KM2 - Key metrics - MREL | 3 |
Table 3: IFRS 9/Article 468 - Impact of IFRS 9 transitional arrangements and temporary | 4 |
treatment in accordance with CRR Article 468 | |
Table 4: UK OV1 - Overview of Risk weighted exposure amounts | 5 |
Annex VII: Own funds | |
Table 5: UK CC1 - Composition of regulatory own funds | 6 |
Table 6: UK CC2 - Reconciliation of regulatory own funds to balance sheet in the audited | 8 |
financial statements | |
Annex IX: Countercyclical capital buffers | |
Table 7: UK CCyB1 - Geographical distribution of credit exposures relevant for the | 9 |
calculation of the countercyclical buffer | |
Table 8: UK CCyB2 - Amount of institution-specific countercyclical capital buffer | 9 |
Annex XI: Leverage Ratio | |
Table 9: UK LR1 - LRSum - Summary reconciliation of accounting assets and leverage ratio | 10 |
exposures | |
Table 10: UK LR2 - LRCom - Leverage ratio common disclosure | 11 |
Table 11: UK LR3 - LRSpl - Split-up of on balance sheet exposures (excluding derivatives, | 12 |
SFTs and exempted exposures) | |
Annex XIII: Liquidity requirements | |
Table 12: UK LIQ1 - Quantitative information on LCR | 13 |
UK LIQB - Qualitative information on LCR | 14 |
Table 13: UK LIQ2 - Net Stable Funding Ratio | 15 |
Annex XV: Credit risk quality | |
Table 14: UK CR1 - Performing and non-performing exposures and related provisions | 19 |
Table 15: UK CR1-A - Maturity of exposures | 21 |
Table 16: UK CR2 - Changes in the stock of non-performing loans and advances | 21 |
Table 17: UK CQ1 - Credit quality of forborne exposures | 22 |
Table 18: UK CQ5 - Credit quality of loans and advances to non-financial corporations by | 23 |
industry | |
Annex XVII: Credit risk mitigation (CRM) techniques | |
Table 19: UK CR3 - Disclosure of the use of credit risk mitigation techniques | 25 |
Annex XIX: Standardised approach | |
Table 20: UK CR4 - Standardised approach: Credit risk exposure and CRM effects | 26 |
Table 21: UK CR5 - Standardised approach | 27 |
Annex XXI: IRB approach to credit risk | |
UK CR6 - IRB approach - Credit risk exposures by exposure class and PD range | 28 |
Table 22: Clydesdale Bank PLC Retail Mortgages - (AIRB) Retail Secured by Immovable | 28 |
Property non-SME |
Table 23: Virgin Money Retail Mortgages - (AIRB) Retail Secured by Immovable Property | 30 |
non-SME | |
Table 24: Clydesdale Bank PLC Business Lending - (FIRB) Corporates: Business | 32 |
Table 25: Clydesdale Bank PLC Corporates - Other - (FIRB) Corporates: Other | 34 |
Table 26: UK CR7-A - IRB approach: Disclosure of the extent of the use of CRM techniques | 36 |
- AIRB | |
Table 27: UK CR7-A - IRB approach: Disclosure of the extent of the use of CRM techniques | 37 |
- FIRB | |
Table 28: UK CR8 - RWA flow statements of credit risk exposures under the IRB approach | 38 |
Annex XXIII: Specialised lending | |
Table 29: UK CR10.2 - Specialised lending and equity exposures under the simple risk | 39 |
weighted approach - Specialised lending: Income-producing real estate and high volatility | |
commercial real estate (Slotting approach) | |
Annex XXV: Counterparty credit risk | |
Table 30: UK CCR1 - Analysis of CCR exposure by approach | 40 |
Table 31: UK CCR2 - Transactions subject to own funds requirements for CVA risk | 40 |
Table 32: UK CCR3 - Standardised approach: CCR exposures by regulatory exposure class | 41 |
and risk weights | |
Table 33: UK CCR8 - Exposures to CCPs | 41 |
Annex XXVII: Securitisation positions | |
Table 34: UK SEC1 - Securitisation exposures in the non-trading book | 42 |
Table 35: UK SEC5 - Exposures securitised by the institution: Exposures in default and | 42 |
specific credit risk adjustments | |
Annex XXXVII: Interest rate risk in the banking book (IRRBB) | |
Table 36: UK IRRBB1 - Quantitative information on IRRBB | 43 |
Appendix 1: Disclosures for CB Group consolidated | |
Table 37: UK KM1 - Key metrics | 44 |
Table 38: UK KM2 - Key metrics - MREL | 45 |
Table 39: IFRS 9/Article 468 - Impact of IFRS 9 transitional arrangements and temporary | 46 |
treatment in accordance with CRR Article 468 | |
Table 40: UK OV1 - Overview of Risk weighted exposure amounts | 47 |
Table 41: UK CC1 - Composition of regulatory own funds | 48 |
Table 42: UK CC2 - Reconciliation of regulatory own funds to balance sheet in the audited | 50 |
financial statements | |
Table 43: UK LR1 - LRSum - Summary reconciliation of accounting assets and leverage | 52 |
ratio exposures | |
Table 44: UK LR2 - LRCom - Leverage ratio common disclosure | 53 |
Table 45: UK LR3 - LRSpl - Split-up of on balance sheet exposures (excluding derivatives, | 54 |
SFTs and exempted exposures) | |
Appendix 2: Glossary | 55 |
Appendix 3: Abbreviations | 59 |
Introduction
FORWARD-LOOKING STATEMENTS
This report and any other written or oral material discussed or distributed in connection with the Pillar 3 disclosures (the "Information") has been produced to meet the regulatory requirements of Virgin Money UK PLC ('Virgin Money' or 'the Company'), together with its subsidiary undertakings (which comprise 'the Group') and is for information only, and should not be regarded as an investment or research recommendation, or any form of investment or business advice. You should not place reliance on the Information when taking any business, legal or other types of decisions/actions.
The Information may include forward looking statements, which are based on assumptions, expectations, valuations, targets and estimates about future events. These can be identified by the use of words such as 'expects', 'aims', 'targets', 'seeks', 'anticipates', 'plans', 'intends', 'prospects' 'outlooks', 'projects', 'forecasts', 'believes', 'estimates', 'potential', 'possible', and similar words or phrases. These forward looking statements are subject to risks, uncertainties and assumptions about the Group and its securities, investments and the environment in which it operates, including, among other things, the development of its business and strategy, any acquisitions, combinations, disposals or other corporate activity undertaken by the Group, trends in its operating industry, changes to customer behaviours and covenant, macroeconomic and/or geopolitical factors, the repercussions of the outbreak of coronaviruses (including but not limited to the COVID-19 pandemic), changes to its board and/ or employee composition, exposures to terrorist activity, IT system failures, cyber- crime, fraud and pension scheme liabilities, risks relating to environmental matters such as climate change including the Group's ability along with the government and other stakeholders to measure, manage and mitigate the impacts of climate change effectively, changes to law and/or the policies and practices of the Bank of England, the Financial Conduct Authority and/or other regulatory and governmental bodies, inflation, deflation, interest rates, exchange rates, tax and national insurance rates, changes in the liquidity, capital, funding and/ or asset position and/or credit ratings of the Group, future capital expenditures and acquisitions, the repercussions
of the UK's exit from the European Union (EU) (including any change to the UK's currency and the terms of any trade agreements (or lack thereof) between the UK and the EU), Eurozone instability, Russia's invasion of
Ukraine, the conflict in the Middle East, any referendum on Scottish independence, and any UK or global cost of living crisis or recession.
These forward-looking statements involve inherent risks and uncertainties and should be viewed as hypothetical. The events they refer to may not occur as expected and other events not taken into account may occur which could significantly affect the analysis of the statements. No member of the Group or their respective directors, officers, employees, agents, advisers, or affiliates (each a "VMUK Party") gives any representation, warranty or assurance that any such events, projections or estimates will occur or be realised, or that actual returns or other results will not be materially lower than those expected.
Whilst every effort has been made to ensure the accuracy of the Information, no VMUK Party takes any responsibility for the Information or to update or revise it. They will not be liable for any loss or damages incurred through the reliance on or use of it. The Information is subject to change. No representation or warranty, express or implied, as to the truth, fullness, fairness, merchantability, accuracy, sufficiency, or completeness of the Information is given.
The Information does not constitute or form part of, and should not be construed as, any public offer under any applicable legislation or an offer to sell or solicitation of any offer to buy any securities or financial instruments or any advice or recommendation with respect to such securities or other financial instruments. The distribution of the Information in certain jurisdictions may be restricted by law. Recipients are required to inform themselves about and to observe any such restrictions. No liability is accepted in relation to the distribution or possession of the Information in any jurisdiction.
No statement in the Information is intended as a profit forecast, profit estimate or quantified benefit statement for any period and no statement in the Information should be interpreted to mean that earnings per share for the Company for the current or future financial years would necessarily match or exceed the historical published earnings or earnings per share for the Company or the Group.
BASIS OF PRESENTATION
This report presents the consolidated half-year Pillar 3 disclosures of the Group as at 31 March 2024 and should be read in conjunction with the Virgin Money UK PLC 2024 Interim Financial Report, available from: www.virginmoneyukplc.com/investor-relations/results-and-reporting/financial-results.
The Group is regulated under UK Capital Requirements Regulation (CRR) and the associated binding technical standards that were created by the European Union (Withdrawal) Act 2018. The CRR has subsequently been amended by a number of statutory instruments and is split across the Prudential Regulatory Authority (PRA) rulebook and primary legislation.
These disclosures are prepared and presented in accordance with the Disclosure (CRR) part of the PRA Rulebook, which includes revised disclosure requirements applicable from 1 January 2022, following the UK implementation of the remaining provisions of CRR II. Any references to the EU regulations and directives
should, as applicable, be read as references to the UK's version of the respective regulation, as onshored into
UK law under the European Union (Withdrawal) Act 2018.
The Group has assessed itself as a 'Large' institution and in accordance with the criteria set out within Article 433a of the PRA rulebook, reports a subset of Pillar 3 disclosures on a quarter and interim period-end basis with full disclosure on an annual basis.
The numbers presented within this report are on a consolidated basis, with Virgin Money UK PLC numbers shown in the body of the report. Consolidated numbers specifically relating to Clydesdale Bank PLC and its subsidiaries are shown in Appendix 1, which aligns with the Disclosure (CRR) part of the PRA Rulebook to report ring-fenced bodies at a sub-consolidated level.
These disclosures have been subject to internal verification and are reviewed by the Board and Disclosure Committee. The disclosures have not been, and are not required to be, subject to independent external audit.
Capital and leverage ratios reported include profits for the period that have been externally verified, less foreseeable dividends.
Certain figures contained in this report may have been subject to rounding adjustments and foreign exchange conversions. Accordingly, in certain instances, the sum or percentage change of the numbers contained in this report may not conform exactly to the total figure given.
Comparative figures are reported to give insight into movements during the period. Where disclosures are new, or have been significantly changed, we do not generally restate or provide prior period comparatives. Where specific rows and columns in the tables prescribed by the PRA are not applicable or are immaterial to our activities, we omit them and follow the same approach for comparative disclosure.
TEMPLATES NOT DISCLOSED
Specific Pillar 3 templates are required to be disclosed on a semi-annual basis and these are included within this report. A subset of the Pillar 3 templates that are required to be disclosed on a semi-annual basis were not applicable to the Group at 31 March 2024 and therefore have not been included in this report, please refer to the 2023 Pillar 3 Disclosures for further details.
Article 432 of the PRA Rulebook on non-material, proprietary or confidential information permits institutions to omit one or more disclosures if the information provided by such a disclosure is not regarded as material. No disclosures have been omitted on the basis of them being regarded as proprietary, confidential or not material.
1
Annex I: Disclosure of key metric and overview of risk weighted exposure amounts
Table 1: UK KM1 - Key metrics
The table below provides a summary of the main prudential regulation ratios and measures.
A | B | C | D | E |
31 Mar 2024 | 31 Dec 2023 | 30 Sept 2023 | 30 June 2023 | 31 Mar 2023 |
£m | £m | £m | £m | £m |
Available own funds (amounts) | ||||||
1 | Common Equity Tier 1 (CET1) capital | 3,731 | 3,522 | 3,711 | 3,637 | 3,627 |
2 | Tier 1 capital | 4,566 | 4,357 | 4,305 | 4,231 | 4,221 |
3 | Total capital | 5,339 | 5,130 | 5,327 | 5,253 | 5,242 |
Risk-weighted exposure amounts | ||||||
4 | Total risk-weighted exposure amount | 25,581 | 25,458 | 25,176 | 24,898 | 24,703 |
Capital ratios (as a percentage of risk-weighted exposure amount) (%) | ||||||
5 | Common Equity Tier 1 ratio | 14.6% | 13.8% | 14.7% | 14.6% | 14.7% |
6 | Tier 1 ratio | 17.8% | 17.1% | 17.1% | 17.0% | 17.1% |
7 | Total capital ratio | 20.9% | 20.2% | 21.2% | 21.1% | 21.2% |
Additional own funds requirements based on Supervisory Review and Evaluation Process | (SREP) (as a | percentage of risk-weighted exposure amount) (%) | ||||
UK-7a | Additional CET1 SREP requirements | 1.9% | 1.9% | 1.7% | 1.7% | 1.7% |
UK-7b | Additional AT1 SREP requirements | 0.6% | 0.6% | 0.6% | 0.6% | 0.6% |
UK-7c | Additional T2 SREP requirements | 0.9% | 0.9% | 0.7% | 0.7% | 0.7% |
UK-7d | Total SREP own funds requirements | 11.4% | 11.4% | 11.0% | 11.0% | 11.0% |
Combined buffer requirement (as a percentage of risk-weighted exposure amount) (%) | ||||||
8 | Capital conservation buffer | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% |
9 | Institution specific countercyclical capital buffer | 2.0% | 2.0% | 2.0% | 1.0% | 1.0% |
UK-10a | Other Systemically Important Institution buffer(1) | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
11 | Combined buffer requirement | 4.5% | 4.5% | 4.5% | 3.5% | 3.5% |
UK-11a | Overall capital requirements | 15.9% | 15.9% | 15.5% | 14.5% | 14.5% |
12 | CET1 available after meeting the total SREP own funds requirements | 8.2% | 7.4% | 8.5% | 8.4% | 8.5% |
Leverage ratio(2)(4) | ||||||
13 | Total exposure measure excluding claims on central banks | 85,720 | 86,624 | 86,554 | 86,052 | 86,464 |
14 | Leverage ratio excluding claims on central banks (%) | 5.3% | 5.0% | 5.0% | 4.9% | 4.9% |
Additional leverage ratio disclosure requirements (%) | ||||||
UK-14a | Fully loaded Expected Credit Loss (ECL) accounting model leverage ratio excluding claims on | 5.3% | 4.9% | 4.9% | 4.8% | 4.8% |
central banks | ||||||
UK-14b | Leverage ratio including claims on central banks | 4.7% | 4.6% | 4.5% | 4.4% | 4.4% |
UK-14c | Average leverage ratio excluding claims on central banks | 5.1% | 4.9% | 4.9% | 4.8% | 4.7% |
UK-14d | Average leverage ratio including claims on central banks | 4.6% | 4.4% | 4.4% | 4.3% | 4.3% |
UK-14e | Countercyclical leverage ratio buffer | 0.7% | 0.7% | 0.7% | 0.4% | 0.4% |
2
Annex I: Disclosure of key metric and overview of risk weighted exposure amounts
Table 1: UK KM1 - Key metrics (continued) | |||||||
B | C | D | E | ||||
A | |||||||
31 Mar 2024 | 31 Dec 2023 | 30 Sept 2023 | 30 June 2023 | 31 Mar 2023 | |||
£m | £m | £m | £m | £m | |||
Liquidity Coverage Ratio(3) | |||||||
15 | Total high-quality liquid assets (HQLA) (Weighted value average) | 14,135 | 13,988 | 13,798 | 13,381 | 12,542 | |
UK-16a | Cash outflows - Total weighted value | 9,957 | 9,887 | 9,933 | 9,875 | 9,573 | |
UK-16b | Cash inflows - Total weighted value | 570 | 540 | 509 | 528 | 553 | |
16 | Total net cash outflows (adjusted value) | 9,387 | 9,347 | 9,424 | 9,347 | 9,020 | |
17 | Liquidity coverage ratio (%) | 151% | 150% | 146% | 143% | 139% | |
Net Stable Funding Ratio (NSFR) | |||||||
18 | Total available stable funding | 79,175 | 78,895 | 79,218 | 79,096 | 78,035 | |
19 | Total required stable funding | 58,385 | 58,317 | 58,346 | 58,247 | 57,943 | |
20 | NSFR ratio (%) | 136% | 135% | 136% | 136% | 135% |
- On 29 November 2022 the Group was formally designated as an O-SII but is not currently required to hold a related capital buffer.
- The average leverage exposure measure (excluding claims on central banks) for the period from 1 January 2024 to 31 March 2024 amounted to £86,214m.
- Liquidity balances are calculated as the simple averages of month-end observations over the 12 months preceding the reporting date.
- The comparative figures include a restatement to qualifying central bank claims which have been adjusted to exclude unencumbered note cover and payment system collateral balances.
Table 2: UK KM2 - Key metrics - MREL
Under the Bank Recovery and Resolution Directive the Group is required to hold additional loss-absorbing instruments to support an effective resolution. The minimum requirements for own funds and eligible liabilities (MREL) establishes a minimum amount of equity and eligible debt to recapitalise the Group. An analysis of the Group's current MREL position is provided below:
A | B | C | D | E | ||
31 Mar 2024 | 31 Dec 2023 | 30 Sept 2023 | 30 June 2023 | 31 Mar 2023 | ||
£m | £m | £m | £m | £m | ||
1 | Total capital resources(1) | 5,339 | 5,130 | 5,327 | 5,253 | 5,242 |
2 | Eligible senior unsecured securities issued by Virgin Money UK PLC | 3,333 | 2,708 | 2,707 | 2,401 | 2,420 |
3 | Total MREL resources | 8,672 | 7,838 | 8,034 | 7,654 | 7,662 |
4 | Total risk weighted assets | 25,581 | 25,458 | 25,176 | 24,898 | 24,703 |
5 | Total MREL resources available as a percentage of total risk weighted assets (%) | 33.9% | 30.8% | 31.9% | 30.7% | 31.0% |
6 | UK leverage exposure measure(2) | 85,720 | 86,624 | 86,554 | 86,052 | 86,464 |
7 | Total MREL resources available as a percentage of UK leverage exposure measure (%)(2) | 10.1% | 9.0% | 9.3% | 8.9% | 8.9% |
- The capital position reflects the application of the transitional arrangements for IFRS 9.
- The comparative figures include a restatement to qualifying central bank claims which have been adjusted to exclude unencumbered note cover and payments system collateral balances.
3
Annex I: Disclosure of key metric and overview of risk weighted exposure amounts
Table 3: IFRS 9/Article 468 - Impact of IFRS 9 transitional arrangements and temporary treatment in accordance with CRR Article 468
The following table shows the capital, RWA and leverage positions with and without the application of transitional arrangements for IFRS 9 or analogous ECLs.
A | B | C | D | E | |||||
31 Mar 2024 | 31 Dec 2023 | 30 Sept 2023 | 30 June 2023 | 31 Mar 2023 | |||||
£m | £m | £m | £m | £m | |||||
Available capital (£m) | |||||||||
1 | Common Equity Tier 1 (CET1) capital | 3,731 | 3,522 | 3,711 | 3,637 | 3,627 | |||
2 | CET1 capital as if IFRS 9 or analogous ECLs transitional arrangements had not been applied | 3,693 | 3,439 | 3,599 | 3,541 | 3,537 | |||
3 | Tier 1 capital | 4,566 | 4,357 | 4,305 | 4,231 | 4,221 | |||
4 | Tier 1 capital as if IFRS 9 or analogous ECLs transitional arrangements had not been applied | 4,528 | 4,274 | 4,193 | 4,135 | 4,131 | |||
5 | Total capital | 5,339 | 5,130 | 5,327 | 5,253 | 5,242 | |||
6 | Total capital as if IFRS 9 or analogous ECLs transitional arrangements had not been applied | 5,301 | 5,047 | 5,215 | 5,157 | 5,152 | |||
Risk-weighted assets (£m) | |||||||||
7 | Total risk-weighted assets | 25,581 | 25,458 | 25,176 | 24,898 | 24,703 | |||
8 | Total risk-weighted assets as if IFRS 9 or analogous ECLs transitional arrangements had not | 25,551 | 25,393 | 25,087 | 24,822 | 24,632 | |||
been applied | |||||||||
Capital ratios (%) | |||||||||
9 | CET1 (as a percentage of risk exposure amount) | 14.6% | 13.8% | 14.7% | 14.6% | 14.7% | |||
10 | CET1 (as a percentage of risk exposure amount) as if IFRS 9 or analogous ECLs transitional | 14.5% | 13.5% | 14.3% | 14.3% | 14.4% | |||
arrangements had not been applied | |||||||||
11 | Tier 1 (as a percentage of risk exposure amount) | 17.8% | 17.1% | 17.1% | 17.0% | 17.1% | |||
12 | Tier 1 (as a percentage of risk exposure amount) as if IFRS 9 or analogous ECLs transitional | 17.7% | 16.8% | 16.7% | 16.7% | 16.8% | |||
arrangements had not been applied | |||||||||
13 | Total capital (as a percentage of risk exposure amount) | 20.9% | 20.2% | 21.2% | 21.1% | 21.2% | |||
14 | Total capital (as a percentage of risk exposure amount) as if IFRS 9 or analogous ECLs | 20.7% | 19.9% | 20.8% | 20.8% | 20.9% | |||
transitional arrangements had not been applied | |||||||||
Leverage ratio | |||||||||
15 | Leverage ratio total exposure measure (£m) | 85,720 | 86,624 | 86,554 | 86,052 | 86,464 | |||
16 | Leverage ratio (%) | 5.3% | 5.0% | 5.0% | 4.9% | 4.9% | |||
17 | Leverage ratio as if IFRS 9 or analogous ECLs transitional arrangements had not been | 5.3% | 4.9% | 4.9% | 4.8% | 4.8% | |||
applied (%) |
Transitional arrangements in CRR mean the regulatory capital impact of ECL is being phased in over time. Following the CRR Quick Fix amendments package, which applied from 27 June 2020, relevant provisions raised from 1 January 2020 through to 2024 have a CET1 add-back percentage of 50% in 2023, reducing to 25% in 2024. From 1 January 2025, the Group will no longer apply transitional relief in respect of IFRS 9. At 31 March 2024, £38m of IFRS 9 transitional adjustments (FY23: £112m) have been applied to the Group's capital position in accordance with CRR, which is entirely comprised of dynamic relief (FY23: £3m static and £109m dynamic).
4
Annex I: Disclosure of key metric and overview of risk weighted exposure amounts
Table 4: UK OV1 - Overview of Risk weighted exposure amounts
The table below shows RWAs and minimum capital requirement by risk type and approach(1). Total own funds requirements are calculated as 8% of RWAs.
A | B | C | |||
Risk weighted exposure amounts | Total own funds | ||||
(RWAs) | requirements | ||||
31 Mar 2024 | 31 Dec 2023 | 31 Mar 2024 | |||
£m | £m | £m | |||
1 | Credit risk (excluding CCR) | 22,391 | 22,301 | 1,790 | |
2 | of which: the standardised approach | 6,692 | 6,657 | 534 | |
3 | of which: the foundation IRB (FIRB) approach | 6,774 | 6,494 | 542 | |
4 | of which: slotting approach | 479 | 399 | 38 | |
5 | of which: the advanced IRB (AIRB) approach | 8,446 | 8,751 | 676 | |
6 | Counterparty credit risk - CCR | 357 | 324 | 29 | |
7 | of which: the standardised approach | 154 | 159 | 13 | |
UK-8a | of which: exposures to a Central Counterparty (CCP) | 5 | 6 | - | |
UK-8b | of which: credit valuation adjustment - CVA | 198 | 159 | 16 | |
23 | Operational risk | 2,833 | 2,833 | 227 | |
UK-23b | of which: standardised approach | 2,833 | 2,833 | 227 | |
24 | Amounts below the thresholds for deduction (subject to 250% | 289 | 300 | 23 | |
risk weight) (For information) | |||||
29 | Total | 25,581 | 25,458 | 2,046 |
- The Group's Pillar 1 capital requirement for market risk is set to zero, therefore no figures are disclosed.
RWAs stayed relatively stable in the period, increasing by £123m (0.5%) to £25,581m.
5
Annex VII: Own Funds
Table 5: UK CC1 - Composition of regulatory own funds | 30 Sept 2023 | |||
31 Mar 2024 | ||||
£m | £m | Ref(1): | ||
CET1 capital: instruments and reserves | ||||
1 | Capital instruments and the related share premium accounts | 140 | 143 | f |
of which: ordinary shares | 130 | 134 | g | |
of which: share premium | 10 | 9 | h | |
2 | Retained earnings | 3,011 | 3,342 | o+q+s |
3 | Accumulated other comprehensive income (and other reserves) | 1,452 | 1,370 | j+k+l+n+u+v |
UK-5a | Independently reviewed interim profits net of any foreseeable charge or dividend | 178 | 117 | p+r+t |
6 | CET1 capital before regulatory adjustments | 4,781 | 4,972 | |
CET1 capital: regulatory adjustments | ||||
7 | Additional value adjustments (negative amount) | (6) | (5) | |
8 | Intangible assets (net of related tax liability) (negative amount) | (150) | (173) | a |
10 | Deferred tax assets that rely on future profitability excluding those arising from temporary differences (net of related tax liability | (245) | (261) | b |
where the conditions in Article 38 (3) CRR are met) (negative amount) | ||||
11 | Fair value reserves related to gains or losses on cash flow hedges of financial instruments that are not valued at fair value | (250) | (496) | l |
12 | Negative amounts resulting from the calculation of expected loss amounts | (101) | (103) | |
15 | Defined-benefit pension fund assets (negative amount) | (331) | (333) | c - e |
16 | Direct, indirect and synthetic holdings by an institution of own CET1 instruments (negative amount) | (5) | (2) | m |
UK-27a | Other regulatory adjustments to CET1 capital (including IFRS 9 transitional adjustments when relevant) | 38 | 112 | |
28 | Total regulatory adjustments to CET1 | (1,050) | (1,261) | |
29 | CET1 capital | 3,731 | 3,711 | |
Additional Tier 1 (AT1) capital: instruments | ||||
30 | Capital instruments and the related share premium accounts | 835 | 594 | |
31 | of which: classified as equity under applicable accounting standards | 835 | 594 | i |
44 | AT1 capital | 835 | 594 | |
45 | Tier 1 capital (T1 = CET1 + AT1) | 4,566 | 4,305 | |
Tier 2 (T2) capital: instruments | ||||
46 | Capital instruments and the related share premium accounts | 773 | 1,022 | d |
58 | Tier 2 (T2) capital | 773 | 1,022 | |
59 | Total capital (TC = T1 + T2) | 5,339 | 5,327 | |
60 | Total Risk exposure amount | 25,581 | 25,176 | |
Capital ratios and buffers | ||||
61 | Common Equity Tier 1 (as a percentage of total risk exposure amount) | 14.6% | 14.7% | |
62 | Tier 1 (as a percentage of total risk exposure amount) | 17.8% | 17.1% | |
63 | Total capital (as a percentage of total risk exposure amount) | 20.9% | 21.2% | |
64 | Institution CET1 overall capital requirement (CET1 requirement in accordance with Article 92(1) CRR, plus additional CET1 | 10.9% | 10.7% | |
requirement which the institution is required to hold in accordance with point (a) of Article 104(1) Capital Requirements Directive | ||||
(CRD), plus combined buffer requirement in accordance with Article 128(6) CRD) expressed as % risk exposure amount) | ||||
6 |
Annex VII: Own Funds
Table 5: UK CC1 - Composition of regulatory own funds (continued) | ||||
30 Sept 2023 | ||||
31 Mar 2024 | ||||
£m | £m | Ref(1): | ||
65 | of which: capital conservation buffer requirement | 2.5% | 2.5% | |
66 | of which: countercyclical buffer requirement | 2.0% | 2.0% | |
67 | of which: systemic risk buffer requirement | 0.0% | 0.0% | |
UK-67a | of which: Global Systemically Important Institution (G-SII) or Other Systemically Important Institution (O-SII) buffer | 0.0% | 0.0% | |
68 | Common Equity Tier 1 available to meet buffers (as a percentage of risk exposure amount)(2) | 8.2% | 8.5% | |
Amounts below the thresholds for deduction (before risk weighting) | ||||
75 | Deferred tax assets arising from temporary differences (amount below 17.65% threshold, net of related tax liability where the | 116 | 118 | |
conditions in Article 38 (3) CRR are met) | ||||
Applicable caps on the inclusion of provisions in Tier 2 | ||||
77 | Cap on inclusion of credit risk adjustments in T2 under standardised approach | 86 | 82 | |
79 | Cap for inclusion of credit risk adjustments in T2 under internal ratings-based approach | 94 | 93 |
- Shows cross reference to the balance sheet under regulatory scope of consolidation in Table UK CC2.
- Represents the CET1 ratio after deducting Pillar 1 and 2A requirements.
Common Equity Tier 1
The Group's CET1 capital showed an increase of £20m during the period, with the CET1 ratio (IFRS 9 transitional basis) remaining stable at 14.6% (FY23: 14.7%).
The Group reported a profit after tax of £236m. The capital benefits of this increase were utilised to fund AT1 distributions of £26m, a foreseeable dividend of £26m and share buyback. In November 2023, a £150m share buyback programme was announced with £63m returned to shareholders before the programme was formally cancelled on 2 April due to the potential cash acquisition of the Group by Nationwide. The reduction in standardised IFRS 9 provisions recognised in the period, together with a tapering of relief, reduced the IFRS 9 transitional adjustments by £74m. Other main movements included reductions in the intangible assets balance of £23m and in the deferred tax recognised on tax losses carried forward of £16m, offset by £12m market driven movements in the reserves balance for assets held at fair value.
Total capital and minimum requirements for own funds and eligible liabilities (MREL)
The total capital ratio remained broadly stable at 20.9% (FY23: 21.2%) and the MREL ratio (IFRS 9 transitional basis) when expressed as a percentage of RWAs increased to 33.9% (FY23 31.9%)
or 10.1% when expressed as a percentage of Leverage exposures (FY23: 9.3%).
The Group's MREL position represents prudent headroom of £1.7bn or 6.6% above the binding loss-absorbing capacity (LAC) requirement of 27.3% of RWAs, or 2.0% above the binding LAC requirement of 8.2% when expressed as a percentage of Leverage exposures. Given the surplus to LAC requirements and having refinanced its redemptions in FY24, the Group is not planning any MREL or capital issuance over the remainder of the year, subject to the acquisition process.
7
Annex VII: Own Funds
Table 6: UK CC2 - Reconciliation of regulatory own funds to balance sheet in the financial statements
The following table shows the Group's consolidated accounting and regulatory balance sheets as at 31 March 2024, with references to show linkages to UK CC1.
A | B | |||
Balance sheet as | ||||
in published | Under regulatory | |||
financial | scope of | |||
statements | consolidation(1) | |||
As at 31 March 2024 | £m | £m | Ref: | |
Assets | ||||
1 | Financial instruments at amortised | |||
cost | ||||
2 | Loans and advances to customers | 72,344 | 72,339 | |
3 | Cash and balances with central | 12,930 | 12,930 | |
banks | ||||
4 | Due from other banks | 592 | 595 | |
5 | At FVOCI | 5,764 | 5,764 | |
6 | At FVTPL | |||
7 | Loans and advances to customers | 57 | 57 | |
8 | Derivatives | 44 | 44 | |
9 | Other | 2 | 2 | |
10 | Intangible assets and goodwill | 150 | 150 | a |
11 | Deferred tax | 266 | 266 | |
12 | of which: tax losses carried forward | 247 | 245 | b |
13 | Defined benefit pensions assets | 442 | 442 | c |
14 | Other assets | 442 | 438 | |
15 | Total assets | 93,033 | 93,027 | |
Liabilities | ||||
16 | Financial instruments at amortised | |||
cost | ||||
17 | Customer deposits | 68,663 | 68,658 | |
18 | Debt securities in issue | 9,968 | 9,968 | |
19 | of which: Tier 2 instruments | 773 | 773 | d |
20 | Due to other banks | 6,255 | 6,255 | |
21 | At FVTPL | |||
22 | Derivatives | 210 | 210 | |
23 | Deferred tax | 111 | 111 | |
24 | of which: defined pension benefit | 111 | 111 | e |
scheme surplus | ||||
25 | Provision for liabilities and charges | 61 | 61 | |
26 | Other liabilities | 2,106 | 2,153 | |
27 | Total liabilities | 87,374 | 87,416 |
A | B | |||
Balance sheet as | ||||
in published | Under regulatory | |||
financial | scope of | |||
statements | consolidation(1) | |||
£m | £m | Ref: | ||
Shareholders' Equity | ||||
28 | Share capital and share premium | 140 | 140 | f |
29 | of which: ordinary share capital | 130 | 130 | g |
30 | of which: share premium | 10 | 10 | h |
31 | Other equity instruments | 835 | 835 | i |
32 | Capital reorganisation reserve | (839) | (839) | j |
33 | Merger reserve | 2,128 | 2,128 | k |
34 | Other reserves | 269 | 269 | |
35 | of which: cash flow hedge reserve | 250 | 250 | l |
36 | of which: own shares held | (5) | (5) | m |
37 | of which: other | 24 | 24 | n |
38 | Retained earnings | 3,126 | 3,078 | |
39 | of which: prior period retained | 3,053 | 3,049 | o |
earnings | ||||
40 | of which: profits accrued in the year | 236 | 236 | p |
to date | ||||
41 | of which: FY23 dividends paid | (26) | (26) | q |
42 | of which: FY24 dividends | - | (26) | r |
paid/accrued in the period | ||||
43 | of which: AT1 coupons accrued for | (12) | (12) | s |
regulatory purposes in FY23 | ||||
44 | of which: FY24 AT1 coupons | (14) | (32) | t |
45 | of which: share buyback recognised | (63) | (63) | u |
for regulatory purposes in FY24 | ||||
46 | of which: other movements in | (48) | (48) | v |
retained earnings | ||||
47 | Total shareholders' equity | 5,659 | 5,611 |
- Balance sheet after accruing for foreseeable AT1 coupons and ordinary dividends.
8
Attention: This is an excerpt of the original content. To continue reading it, access the original document here. |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Virgin Money UK plc published this content on 14 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 June 2024 11:14:08 UTC.